• OPEN AN ACCOUNT
Indian Indices
Sensex
76,157.20 -234.19
( -0.31%)
Global Indices
Nasdaq
51,722.16 -517.42
(-0.99%)
Dow Jones
7,429.53 -90.43
(-1.20%)
Hang Seng
66,278.94 163.34
(0.25%)
Nikkei 225
10,630.89 -86.08
(-0.80%)
Forex
USD-INR
96.48 0.17
(0.18%)
EUR-INR
110.06 0.16
(0.15%)
GBP-INR
129.05 -0.06
(-0.05%)
JPY-INR
0.59 0.00
(0.00%)

EQUITY - MARKET SCREENER

Sameera Agro and Infra Ltd
Industry :  Food - Processing - Indian
BSE Code
ISIN Demat
Book Value()
91892
INE0PZA01015
23.0413609
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SAIFL
1.79
29.77
EPS(TTM)
Face Value()
Div & Yield %
2.8
10
0
 

Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12